AORT
Artivion, Inc.NYSEHealthcare$34.21+0.15%ClosedMarket Cap: $1.64B
As of 2026-04-06
Valuation
P/E (TTM)
167.70
PEG
0.97
P/B
3.55
P/S
3.63
EV/EBITDA
31.03
DCF Value
$-2.29
FCF Yield
-0.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
63.6%
Operating Margin
6.9%
Net Margin
2.2%
ROE
2.4%
ROA
1.1%
ROIC
2.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $116.0M | 60.1% | $7.2M | $2.4M | $0.05 | — |
| FY 2025 | $441.3M | 61.3% | $26.7M | $9.8M | $0.21 | — |
| Q3 2025 | $113.4M | 65.6% | $12.5M | $6.5M | $0.13 | — |
| Q2 2025 | $113.0M | 64.7% | $8.4M | $1.3M | $0.03 | — |
| Q1 2025 | $99.0M | 64.2% | $2.1M | $-505.0K | $-0.01 | — |
| Q4 2024 | $97.3M | 63.2% | $2.7M | $-16.5M | $-0.39 | — |
| FY 2024 | $388.5M | 64.0% | $38.9M | $-13.4M | $-0.32 | — |
| Q3 2024 | $95.8M | 63.7% | $4.4M | $-2.3M | $-0.05 | — |
| Q2 2024 | $98.0M | 64.6% | $6.5M | $-2.1M | $-0.05 | — |
| Q1 2024 | $97.4M | 64.6% | $25.3M | $7.5M | $0.18 | — |
| Q4 2023 | $93.7M | 65.2% | $3.2M | $-4.0M | $-0.10 | — |
| FY 2023 | $354.0M | 64.7% | $5.7M | $-30.7M | $-0.75 | — |